Exane Derivatives’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-24
| Closed | -$10.6K | – | 1046 |
|
|
2022
Q1 | $10.6K | Hold |
24
| – | – | ﹤0.01% | 673 |
|
|
2021
Q4 | $10.6K | Hold |
24
| – | – | ﹤0.01% | 581 |
|
|
2021
Q3 | $13.5K | Hold |
24
| – | – | ﹤0.01% | 684 |
|
|
2021
Q2 | $11.8K | Sell |
24
-6
| -20% | -$2.94K | ﹤0.01% | 723 |
|
|
2021
Q1 | $23.6K | Sell |
30
-14
| -32% | -$11K | 0.01% | 542 |
|
|
2020
Q4 | $24.2K | Hold |
44
| – | – | 0.01% | 493 |
|
|
2020
Q3 | $20.4K | Hold |
44
| – | – | 0.01% | 417 |
|
|
2020
Q2 | $27.4K | Hold |
44
| – | – | 0.01% | 365 |
|
|
2020
Q1 | $21.1K | Sell |
44
-180
| -80% | -$86.5K | 0.01% | 382 |
|
|
2019
Q4 | $136K | Sell |
224
-276
| -55% | -$167K | 0.03% | 275 |
|
|
2019
Q3 | $329K | Sell |
500
-56
| -10% | -$36.9K | 0.06% | 184 |
|
|
2019
Q2 | $430K | Buy |
556
+367
| +194% | +$284K | 0.08% | 174 |
|
|
2019
Q1 | $133K | Sell |
189
-11
| -6% | -$7.75K | 0.03% | 253 |
|
|
2018
Q4 | $93.6K | Hold |
200
| – | – | 0.02% | 298 |
|
|
2018
Q3 | $172K | Hold |
200
| – | – | 0.03% | 244 |
|
|
2018
Q2 | $138K | Buy |
+200
| New | +$138K | 0.02% | 270 |
|